Hank Fuchs

Hank Fuchs serves as President of Research and Development at BioMarin Pharmaceutical Inc. and holds board member positions at Mirati Therapeutics, Genomic Health, and Ardea Biosciences. Previously, Hank Fuchs was Chief Medical Officer at Onyx Pharmaceuticals. Educationally, Hank Fuchs earned a Bachelor of Arts in Biochemistry from Harvard College and attended The George Washington University School of Medicine and Health Sciences from 1978 to 1982.